reference/12711157

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12711157

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	136
issn	0914-5087
issueIdentifier	2
pageRange	131-136
publicationName	Journal of Cardiology
startingPage	131
bibliographicCitation	Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, Kaneko S, Aizawa T, Fu LT. Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling. J Cardiol. 2011 Sep;58(2):131–6. doi: 10.1016/j.jjcc.2011.06.003. PMID: 21802905.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_081410f55c1a0a86e7fd225904fcec87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ae523182bcf92f2b113d625040149df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_423557ab46fd2d09c5c3f33513e3de9b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef3bd68e1480060406bba710b8b89ee5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44d03b4128c02ae2186d8c04e0344b3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3375171b2dfb65a45bcf1d551e9bf65b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7da4b494a8993a5a198695819c9d4e69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbdfacf9c8e2f6a8973fa75cd4b035ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05ca3790583fb63b5751ff16fa39fcc4
date	201109
identifier	https://pubmed.ncbi.nlm.nih.gov/21802905 https://doi.org/10.1016/j.jjcc.2011.06.003
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5157 https://portal.issn.org/resource/ISSN/0914-5087
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling
discusses	http://id.nlm.nih.gov/mesh/M0002570 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0430510 http://id.nlm.nih.gov/mesh/M0456879 http://id.nlm.nih.gov/mesh/M0217705 http://id.nlm.nih.gov/mesh/M0002348 http://id.nlm.nih.gov/mesh/M0192848 http://id.nlm.nih.gov/mesh/M000600821
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013777Q000494 http://id.nlm.nih.gov/mesh/D047228Q000494 http://id.nlm.nih.gov/mesh/D003921Q000473 http://id.nlm.nih.gov/mesh/D001562Q000494 http://id.nlm.nih.gov/mesh/D003921Q000188 http://id.nlm.nih.gov/mesh/D006325Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D000067759Q000378 http://id.nlm.nih.gov/mesh/D013777Q000627 http://id.nlm.nih.gov/mesh/D013777Q000008 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D006325Q000378 http://id.nlm.nih.gov/mesh/D047228Q000627 http://id.nlm.nih.gov/mesh/D047228Q000008 http://id.nlm.nih.gov/mesh/D001562Q000008 http://id.nlm.nih.gov/mesh/D001713 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005355 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D001562Q000627 http://id.nlm.nih.gov/mesh/D001145Q000517 http://id.nlm.nih.gov/mesh/D055513Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733335 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29327 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5300 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29655c37cc5095c92874ed103132d52d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713972 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420074 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7067772 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6956 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45357367 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c32c0d8aa4f785d63c80f6f9c7c6be06 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10050

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135758261 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128111715 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81722

Total number of triples: 75.